Published Papers by IgAN Biobank

  1. Schena FP, D'Altri C, Cerullo G, Manno C, Gesualdo L. ACE gene polymorphism and IgA nephropathy. An ethnically homogeneus study and a meta-analysis review. Kidney Int. 2001 Aug;60(2):732-40.

  2. Schena FP. For further investigations in igA nephropathy the approach from phenotype to genotype is welcome. Clin Exp Immunol. 2002 Mar;127(3):399-401.

  3. Schena FP, Cerullo G, Rossini M, Lanzilotta SG, D'Altri C, Manno C. Increased risk of end stage renal disease in familial IgA nephropathy. J Am Soc Nephrol. 2002 Feb;13(2):453-60.

  4. Schena FP, Cerullo G, Torres DD, Scolari F, Foramitti M, Amoroso A, Pirrulli D, Floege J, Mertens Pr, Zerres K, Alexopoulos E, Kirmizis D, Zelante L, Bisceglia L, Ghiggeri Gm, Frasca Gm. The IgA nephropathy Biobank. An important starting point for the genetic dissection of a complex trait. BMC Nephrol. 2005 Dec 5;6:14.

  5. Schena FP, Cerullo G, Torres DD, Scolari F, Foramitti M, Amoroso A, Pirulli D, Floege J, Mertens PR, Zerres K, Alexopoulos E, Kirmizis D, Zelante L, Bisceglia L. Role of interferon-gamma gene polymorphisms in susceptibility to IgA nephropathy: a family-based association study. Eur J Hum Genet. 2006 Apr;14(4):488-96

  6. Izzi C, Sanna-Cherchi S, Prati E, Belleri R, Remedio A, Tardanico R, Foramitti M, Guerini S, Viola BF, Movilli E, Beerman I, Lifton R, Leone L, Gharavi A, Scolari F. Familial aggregation of primary glomerulonephritis in an Italian population isolate: Valtrompia study. Kidney Int. 2006 Mar;69(6):1033-40

  7. Izzi C, Ravani P, Torres DD, Prati E, Viola BF, Guerini S, Foramitti S, Frasca G, Amoroso A, Ghiggeri GM, Schena F, Scolari F. IgA nephropathy: the presence of familial disease does not confer an increased risk for progression. Am J Kidney Dis. 2006 May;47(5):761-9.

  8. Di Duca M, Oleggini R, Sanna-Cherchi S, Pasquali L, Di Donato A, Parodi S, Bertelli R, Caridi G, Frasca G, Cerullo G, Amoroso A, Schena FP, Scolari F, Ghiggeri GM. Cis and trans regulatory elements in NPHS2 promoter: Implications in proteinuria and progression of renal diseases. Kidney Int. 2006 Oct;70(7):1332-41

  9. Biolo G, Amoroso A, Savoldi S, Bosutti A, Martone M, Pirulli D, Bianco F, Ulivi S, Bertok S, Artero M, Barazzoni R, Zanetti M, Grassi G, Guarnieri G, Panzetta G. Association of interferon-{gamma} +874A polymorphism with reduced long-term inflammatory response in haemodialysis patients. Nephrol Dial Transplant. 2006 May;21(5):1317-22.

  10. Bisceglia L, Cerullo G, Forabosco P, Torres DD, Scolari F, Di Perna M, Foramitti M, Amoroso A, Bertok S, Floege J, Mertens PR, Zerres K, Alexopoulos E, Kirmizis D, Ermelinda M, Zelante L, Schena FP; European IgAN Consortium. Genetic heterogeneity in Italian families with IgA nephropathy: suggestive linkage for two novel IgA nephropathy loci. Am J Hum Genet. 2006 Dec;79(6):1130-4.

  11. Schena FP, Cerullo G, Torres DD, Zaza G, Cox S, Bisceglia L, Scolari F, Frasca G, Ghiggeri GM, Amoroso A; on behalf of the European IgA Nephropathy Consortium. Searching for IgA nephropathy candidate genes: Genetic studies combined with high throughput innovative investigations. IgA Nephropathy Today Tomino Y (ed). Contrib Nephrol. Basel, Karger, 2007, vol 157, pp 80-89.

  12. Manno C, Strippoli GFM, D'Altri C, Torres DD, Rossini M, Schena FP on behalf of the European IgAN Consortium. A novel, simpler histological classification for renal survival in IgA nephropathy: a retrospective study. Am J Kidney Dis. 2007 Jun;49(6):763-75.

  13. Bicanski B, Wenderdel M, Mertens PR, Senderek J, Panzer U, Steinmetz O, Stahl RA, Cerullo G, Diletta Torres D, Schena FP, Zerres K, Floege J. PDGF-B gene single-nucleotide polymorphisms are not predictive for disease onset or progression of IgA nephropathy. Clin Nephrol. 2007 Feb;67(2):65-72.